Widespread availability of HAART has dramatically decreased AIDS-related diseases and death since 1996. Furthermore, HAART rapidly and effectively renders HIV undetectable in blood and genital secretions and this is associated with decreased risk of transmission. HAART is therefore the best and most cost-effective means to stop disease progression and death, as well as HIV transmission: the strategy has now been named “Treatment as Prevention” (TasP).
For more information, please download the event flyer.